J
Jan T. Christenson
Researcher at University of Geneva
Publications - 111
Citations - 4032
Jan T. Christenson is an academic researcher from University of Geneva. The author has contributed to research in topics: Coronary artery disease & Mitral valve. The author has an hindex of 35, co-authored 111 publications receiving 3855 citations. Previous affiliations of Jan T. Christenson include Geneva College.
Papers
More filters
Journal ArticleDOI
Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients.
Stéphan Juergen Harbarth,Carolina Fankhauser,Jacques Schrenzel,Jan T. Christenson,Pascal Gervaz,Catherine Bandiera-Clerc,Gesuele Renzi,Nathalie Vernaz,Hugo Sax,Didier Pittet +9 more
TL;DR: A universal, rapid MRSA admission screening strategy did not reduce nosocomial MRSA infection in a surgical department with endemic MRSA prevalence but relatively low rates of MRSA infections.
Journal ArticleDOI
Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients
TL;DR: The beneficial effect of preoperative IABP in high-risk patients who have coronary artery bypass grafting was confirmed and there were no differences in outcome between the subgroups; therefore, at 2 hours preoperatively, IABp therapy can be started.
Journal ArticleDOI
Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry.
Gregg W. Stone,E. Magnus Ohman,Michael F Miller,Debra L. Joseph,Jan T. Christenson,Marc Cohen,Philip Urban,Ramachandra C. Reddy,Robert J. Freedman,Karen L Staman,James J. Ferguson +10 more
TL;DR: With contemporary advances in device technology, insertion technique, and operator experience, IABP counterpulsation may be successfully employed for a wide variety of conditions in the AMI setting, providing significant hemodynamic support with rare major complications in a high-risk patient population.
Journal ArticleDOI
Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry
Marc Cohen,Philip Urban,Jan T. Christenson,Debra L. Joseph,Robert J. Freedman,Michael F Miller,E. Magnus Ohman,Ramachandra C. Reddy,Gregg W. Stone,James J. Ferguson +9 more
TL;DR: IABP counterpulsation is deployed at an earlier clinical stage in US patients, and Mortality rates are higher for non-US patients, particularly for patients with non-surgery cardiac interventions, even after adjusting for risk factors.
Journal ArticleDOI
Prospective randomized trial comparing endovenous laser ablation and surgery for treatment of primary great saphenous varicose veins with a 2-year follow-up.
TL;DR: Abolition of GSV reflux and improvement in quality of life was similar after HL/S and EVLT, and no differences compared with 1-year results were observed.